Skip to main content
Top
Published in: Diabetologia 8/2019

Open Access 01-08-2019 | Article

Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality

Authors: Jean Strelitz, Amy L. Ahern, Gráinne H. Long, Matthew J. L. Hare, Greg Irving, Clare E. Boothby, Nicholas J. Wareham, Simon J. Griffin

Published in: Diabetologia | Issue 8/2019

Login to get access

Abstract

Aims/hypothesis

Adults with type 2 diabetes are at high risk of developing cardiovascular disease (CVD). Evidence of the impact of weight loss on incidence of CVD events among adults with diabetes is sparse and conflicting. We assessed weight change in the year following diabetes diagnosis and estimated associations with 10 year incidence of CVD events and all-cause mortality.

Methods

In a cohort analysis among 725 adults with screen-detected diabetes enrolled in the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)–Cambridge trial, we estimated HRs for weight change in the year following diabetes diagnosis and 10 year incidence of CVD (n = 99) and all-cause mortality (n = 95) using Cox proportional hazards regression. We used linear regression to estimate associations between weight loss and CVD risk factors. Models were adjusted for age, sex, baseline BMI, smoking, occupational socioeconomic status, cardio-protective medication use and treatment group.

Results

Loss of ≥5% body weight in the year following diabetes diagnosis was associated with improvements in HbA1c and blood lipids and a lower hazard of CVD at 10 years compared with maintaining weight (HR 0.52 [95% CI 0.32, 0.86]). The associations between weight gain vs weight maintenance and CVD (HR 0.41 [95% CI 0.15, 1.11]) and mortality (HR 1.63 [95% CI 0.83, 3.19]) were less clear.

Conclusions/interpretation

Among adults with screen-detected diabetes, loss of ≥5% body weight during the year after diagnosis was associated with a lower hazard of CVD events compared with maintaining weight. These results support the hypothesis that moderate weight loss may yield substantial long-term CVD reduction, and may be an achievable target outside of specialist-led behavioural treatment programmes.
Appendix
Available only for authorised users
Literature
4.
go back to reference Look AHEAD Research Group (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170(17):1566–1575 Look AHEAD Research Group (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170(17):1566–1575
9.
go back to reference Williamson DF (1998) Weight loss and mortality in persons with type-2 diabetes mellitus: a review of the epidemiological evidence. Exp Clin Endocrinol Diabetes 106(Suppl 2):14–21PubMed Williamson DF (1998) Weight loss and mortality in persons with type-2 diabetes mellitus: a review of the epidemiological evidence. Exp Clin Endocrinol Diabetes 106(Suppl 2):14–21PubMed
10.
go back to reference Gregg EW, Jakicic JM, Blackburn G et al (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4(11):913–921CrossRef Gregg EW, Jakicic JM, Blackburn G et al (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4(11):913–921CrossRef
14.
go back to reference Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560–2572CrossRef Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560–2572CrossRef
18.
go back to reference Piepoli MF, Hoes AW, Agewall S et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381CrossRef Piepoli MF, Hoes AW, Agewall S et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381CrossRef
26.
go back to reference Elias P, Halstead K, Prandy K (1993) CASOC: computer-assisted standard occupational coding. HMSO, London Elias P, Halstead K, Prandy K (1993) CASOC: computer-assisted standard occupational coding. HMSO, London
29.
go back to reference National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S–209S National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S–209S
Metadata
Title
Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
Authors
Jean Strelitz
Amy L. Ahern
Gráinne H. Long
Matthew J. L. Hare
Greg Irving
Clare E. Boothby
Nicholas J. Wareham
Simon J. Griffin
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-4886-1

Other articles of this Issue 8/2019

Diabetologia 8/2019 Go to the issue

Up Front

Upfront